Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enteroaggregative Escherichia coli: an emerging enteric pathogen.

David B Huang1, Pablo C Okhuysen, Zhi-Dong Jiang

  • 1Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.

The American Journal of Gastroenterology
|March 30, 2004
PubMed
Summary

Enteroaggregative Escherichia coli (EAEC) causes enteric infections, with specific genetic factors increasing susceptibility. Early identification and tailored antimicrobial treatments like ciprofloxacin can shorten EAEC diarrhea duration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbiome alterations during and after international travel.

Journal of travel medicine·2025
Same author

Bezlotoxumab for the prevention of recurrent <i>Clostridioides difficile</i> infection for patients with cancer.

Annals of gastroenterology·2025
Same author

Leaders behind the launching of the international society of travel medicine, the journal of travel medicine and helping to define a new medical discipline.

Journal of travel medicine·2025
Same author

Re-visiting bismuth subsalicylate for the prevention of travellers' diarrhoea.

Journal of travel medicine·2025
Same author

Ten Practical Tips for a Successful Presentation at an Infectious Disease Clinical Case Conference.

Open forum infectious diseases·2025
Same author

The impact of cancer-related diarrhea on changes in cancer therapy.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2024

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genetics

Background:

  • Enteroaggregative Escherichia coli (EAEC) is an emerging pathogen causing enteric and food-borne illnesses globally.
  • EAEC pathogenesis involves intestinal adherence, biofilm formation, and inflammation.
  • Host genetic factors, like the IL-8 promoter SNP, influence EAEC infection susceptibility.

Purpose of the Study:

  • To raise awareness of EAEC as an emerging pathogen.
  • To review the epidemiology and pathogenesis of EAEC infections.
  • To discuss host-pathogen interactions in EAEC disease.

Main Methods:

  • Utilized HEp-2 cell adherent assay to identify EAEC's characteristic "stacked brick" adherence.
  • Reviewed existing literature on EAEC epidemiology and pathogenesis.

Related Experiment Videos

  • Analyzed host genetic factors, specifically the -251 AA SNP in the IL-8 promoter region.

    • Main Results:

    • EAEC infections are influenced by strain heterogeneity and host immune responses.
    • Individuals with the -251 AA genotype in the IL-8 promoter are more susceptible to EAEC diarrhea.
    • Ciprofloxacin and rifaximin significantly reduced diarrhea duration compared to placebo.

    Conclusions:

    • EAEC is a significant emerging enteric pathogen with diverse clinical presentations.
    • Genetic predisposition plays a role in EAEC susceptibility.
    • Individualized antimicrobial therapy, including ciprofloxacin and rifaximin, is effective for EAEC diarrhea.